| I-63 Gudrun Wuerthwein Population pharmacokinetics for PEGylated asparaginase Oncaspar® in children with ALL: differences between protocol parts and predictivity Wednesday 10:10-11:40 |
| I-63 Gudrun Wuerthwein Population pharmacokinetics for PEGylated asparaginase Oncaspar® in children with ALL: differences between protocol parts and predictivity Wednesday 10:10-11:40 |